Experimental Exchange Transfusions for Reducing Azotemia. Use of Artificial Kidney for This Purpose

Thalhimer, William

doi:10.3181/00379727-37-9673p

Cited by 59 publications

(21 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thalhimer described exchange transfusion as a treatment for azotemia in experiments on nephrectomized dogs [54]. Axtrup used it as treatment for poisoning in two children in Sweden, one after ingestion of tablets containing chloramine and the other after ingestion of ink containing an aniline dye [55].…”

Section: Plasmapheresis and Exchange Transfusionmentioning

confidence: 99%

Developments in extracorporeal therapy for the poisoned patient

Patel

Bayliss

2015

Advanced Drug Delivery Reviews

View full text Add to dashboard Cite

Section: Plasmapheresis and Exchange Transfusionmentioning

confidence: 99%

Developments in extracorporeal therapy for the poisoned patient

Patel

Bayliss

2015

Advanced Drug Delivery Reviews

View full text Add to dashboard Cite

“…1 The work described in this paper was done under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University. 2 A sucessful clinical application of the method described in this paper has been reported In the long term experiments water was offered freely. Protein intake was maintained, when the dog refused to eat, by forced feeding of raw eggs.…”

mentioning

confidence: 89%

Treatment of Experimental Uremia by Means of Peritoneal Irrigation 1

Seligman¹,

Frank²,

Fine³

1946

J. Clin. Invest.

View full text Add to dashboard Cite

“…Since their first introduction (Thalheimer 1937), dialysis membranes have grown out to be the application with the largest socio-economic impact, in the first place for their enormous market share and in the second place for the fact that they have a direct influence on the health and well-being of the treated patients. Progress has been made in their performance and careful control of the fibre spinning process now allows the production of underarm-sized modules containing over 1 m 2 of active surface.…”

Section: Introductionmentioning

confidence: 99%

Polymeric membranes with antioxidant activity based on cellulose esters and poly(vinylidene fluoride)/cellulose ester blends

et al. 2011

View full text Add to dashboard Cite

A series of novel cellulose membranes with antioxidant activity was prepared and characterized. Microcrystalline cellulose was functionalized with lipoic acid, ferulic acid and alpha-tocopherol moieties. These materials were characterized by FT-IR and NMR spectroscopy and their degree of substitution (DS) was determined by volumetric analysis. The manuscript discusses the antioxidant activity of cellulose derivatives in inhibiting lipid peroxidation in ratliver microsomal membranes, induced in vitro by two different sources of free radicals: 2,2 0 -azobis-(2-amidinopropane) (AAPH), which exogenously produces peroxyl radicals by thermal decomposition, and tertbutyl hydroperoxide (tert-BOOH), which endogenously produces alkoxyl radicals by Fenton reactions. Membranes were prepared by the nonsolvent-induced phase inversion technique. Membranes of the pure cellulose derivatives were thin, mechanically weak and generally unsuitable for practical application. As an alternative, mechanically resistant poly(vinylidene fluoride)/cellulose ester blend membranes were obtained by direct phase inversion of the polymer/ polymer/solvent mixture. These membranes were characterized by means of water permeability measurements, optical and scanning electron microscopy, determination of the antioxidant activity in comparison with starting materials. The membranes exhibited a good preservation of peroxidation inhibition and the performance of this kind of cellulose membrane as a scavenger of Reactive Oxygen Species (ROS) offers interesting perspectives for an effective control of intradialytic oxidative stress.

show abstract

Experimental Exchange Transfusions for Reducing Azotemia. Use of Artificial Kidney for This Purpose

Cited by 59 publications

References 0 publications

Developments in extracorporeal therapy for the poisoned patient

Developments in extracorporeal therapy for the poisoned patient

Treatment of Experimental Uremia by Means of Peritoneal Irrigation 1

Polymeric membranes with antioxidant activity based on cellulose esters and poly(vinylidene fluoride)/cellulose ester blends

Contact Info

Product

Resources

About